Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

External Lumbar Drainage to Abort Severe Traumatic IntraCranial Hypertension: A Phase 1 Randomized, Allocation-concealed, Open-label, Safety and Feasibility Clinical Trial

NCT05889650 is registered in ClinicalTrials.gov with Brain Trauma Foundation as lead sponsor.

NCT NCT05889650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05889650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
External Lumbar Drainage to Abort Severe Traumatic IntraCranial Hypertension: A Phase 1 Randomized, Allocation-concealed, Open-label, Safety and Feasibility Clinical Trial
Lead sponsor
Brain Trauma Foundation
Phase
Not applicable
Overall status
Recruiting
Start date
June 24, 2024
Completion date
June 30, 2028
Enrollment
30 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial hypertension, severe traumatic brain injury